TL;DR
Respiratory infections like colds and flu are widespread and challenging to combat due to their many mutating strains. Intercept is a $500 million initiative aimed at developing broad-spectrum preventatives and air cleaning technologies to address this issue.
✦ Why It Matters
Engineers and researchers can explore new funding opportunities and technologies for developing broad-spectrum antiviral solutions.
Key Takeaways
Full Summary
Historically, respiratory infections have been as prevalent as waterborne diseases were a century ago, yet efforts to combat them have lagged. Intercept is a philanthropic initiative with a $500 million budget focused on creating broad-spectrum solutions, which are designed to target multiple strains of respiratory viruses simultaneously.
The initiative leverages recent advancements in human immunology, biological data sets, and protein design tools to develop effective preventatives and air cleaning technologies. A symposium with experts revealed that while technical challenges exist, the necessary tools are now available.
The goal is to catalyze innovation in this area, which has been underfunded compared to other health initiatives. If successful, these technologies could drastically reduce the incidence of respiratory infections, improving public health outcomes significantly.
Related